VEXT — Vext Science Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual cashflow statement for Vext Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	2.13	4.99	10.9	4.4	-22.4
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	1.39	3.31	-0.233	-13.6	8.64
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-3.07	-1.74	-7.18	7.04	0.593
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities	3.1	11.7	5.72	4.42	3.29
Capital Expenditures	-4.06	-18.8	-8.86	-2.74	-1.47
Purchase of Fixed Assets
Other Investing Cash Flow Items	-8.84	-8.31	-21.5	-2.09	-3.97
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-12.9	-27.1	-30.3	-4.82	-5.44
Financing Cash Flow Items	-0.5	-1.5	-1.63	-1.03	-1.74
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	4.26	20.1	24.1	3.19	-1.95
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-5.55	4.72	-0.533	2.79	-4.1